|
Volumn 147, Issue , 1998, Pages 67-82
|
Percutaneous isolated liver chemoperfusion for treatment of unresectable malignant liver tumors: technique, pharmacokinetics, clinical results.
a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DOXORUBICIN;
ARTICLE;
DOSE RESPONSE;
DRUG EFFECT;
HEMODYNAMICS;
HEMOPERFUSION;
HEPATIC ARTERY;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TUMOR;
METABOLISM;
MORTALITY;
REGIONAL PERFUSION;
SURVIVAL RATE;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
CISPLATIN;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOXORUBICIN;
HEMODYNAMIC PROCESSES;
HEMOPERFUSION;
HEPATIC ARTERY;
HUMANS;
LIVER NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 0031616158
PISSN: 00800015
EISSN: None
Source Type: Journal
DOI: 10.1007/978-3-642-80460-1_8 Document Type: Article |
Times cited : (16)
|
References (0)
|